US2004203080A1PendingUtilityA1

7 transmembrane receptor family member BLRx

62
Priority: Jul 25, 1997Filed: Mar 19, 2004Published: Oct 14, 2004
Est. expiryJul 25, 2017(expired)· nominal 20-yr term from priority
A61K 39/00C07K 14/522C07K 14/705C07K 14/521C07K 14/7158
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A substantially pure polypeptide comprising at least 26 contiguous amino acids of the amino acid sequence set forth in SEQ ID NO: 8.  
     
     
         2 . A kit comprising said polypeptide of  claim 1  and instructions for use or disposal of reagents in said kit.  
     
     
         3 . A substantially pure polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 8.  
     
     
         4 . A kit comprising said polypeptide of  claim 3  and instructions for use or disposal of reagents in said kit.  
     
     
         5 . The polypeptide of  claim 3  wherein the polypeptide is detectably labeled.  
     
     
         6 . The polypeptide of  claim 3  wherein the polypeptide is attached to a solid substrate.  
     
     
         7 . The polypeptide of  claim 3  wherein the polypeptide is a fusion protein.  
     
     
         8 . A substantially pure polypeptide comprising a polypeptide that is a 3-fold or less substituted form of the polypeptide defined by the amino acid sequence set forth in SEQ ID NO: 8.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.